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The recently discovered potent role of mi-
croRNAs (miRNAs) in regulation of gene and 
protein expression suggests an important role 
for these small RNAs in regulation of various 
physiological processes. miRNAs are  21-nt-
long noncoding RNAs that are processed from 
endogenously generated  70-nt-long hairpin 
structures by the RNase III enzyme Dicer. 
The nascent miRNA is incorporated into the 
RNA-induced silencing complex that mediates 
miRNA-dependent translational suppression or, 
in rare cases, cleavage of respective mRNA 
targets (for review see references 1–3). Abla-
tion of the miRNA-generating enzyme Dicer 
revealed a requirement for miRNAs in devel-
opment of immune cells (4–6), skin progeni-
tors (7), and limb outgrowth (8). The predicted 
role of miRNAs in regulation of mammalian 
cell function has been underscored by fi  ndings 
that show the ability of individual miRNAs to 
aff  ect diff  erentiation and function of cells of 
various lineages, including T cells (9) and cardiac 
myocytes (10, 11).
Several lines of evidence indicate the possi-
bility of an important role of miRNAs in neu-
ronal cells. Compared with other organs, both 
mouse and human brain express an exceptionally 
diverse spectrum of distinct miRNAs (12–16). 
Furthermore, the existence of neuron-specifi  c 
miRNAs argues in favor of their important 
role in neuronal diff  erentiation and/or special-
ized functions. The involvement of miRNAs 
in neuronal diff  erentiation is strongly supported 
by dynamic changes in miRNA expression dur-
ing brain development (14, 17, 18). Moreover, 
the ability of neuron-specifi  c miRNA miR-124a 
to suppress expression of nonneuronal genes in 
an in vitro cell system suggests an important 
role for miRNAs as regulators of neuronal dif-
ferentiation (19). The signifi  cance of miRNAs 
in neuronal physiology is also suggested by 
data that show miRNA involvement in den-
dritic spine formation and neurite outgrowth 
in vitro (20, 21). In summary, although there 
is mounting evidence for important roles for 
miRNAs in neuron cell diff  erentiation, their role 
in diff  erentiated, postmitotic neurons has not 
been addressed.
Using Purkinje cells as a model system to 
analyze the role of miRNAs in postmitotic 
neurons, we demonstrate an essential role for 
miRNAs in neuronal survival. We show that 
inactivation of Dicer leads to relatively rapid dis-
appearance of Purkinje cell–expressed miRNAs, 
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followed by a slow degeneration of the Purkinje cells. The 
loss of Dicer and the decay of miRNAs have no immediate 
impact on Purkinje cell function as analyzed by Purkinje cell 
electrophysiological characteristics and animal locomotion. 
However, the continuous lack of miRNAs leads eventually to 
Purkinje cell death and ataxia. Collectively, our data suggest 
that miRNAs are essential for the survival of Purkinje cells and 
their absence leads to a slow degeneration of these cells.
RESULTS AND DISCUSSION
Dicer inactivation in differentiated Purkinje cells
The ubiquitously expressed endonuclease Dicer is essential 
for the generation of miRNAs (22, 23). To address the role 
of miRNAs in postmitotic, diff  erentiated neurons, we used 
postnatal ablation of the miRNA-generating enzyme Dicer 
in Purkine cells. There were several reasons for choosing 
Purkinje cells as a model system for the analysis of miRNA 
function: (a) Purkinje cells have a well-defi  ned anatomic 
location and morphology; (b) these cells are easy to quan-
tify; (c) their electrophysiological characteristics are well 
  established; (d) changes in Purkinje cell physiology or sur-
vival lead to a characteristic functional phenotype consisting 
of a profound ataxia; and (e) the conditional inactivation of 
loxP-fl  anked gene segments in Purkinje cells could be achieved 
by using Purkinje cell–specifi  c Pcp2 promotor–driven Cre 
recombinase (24). Importantly, the Pcp2 gene remains silent 
until the second week after birth, at which time Purkinje 
cells are postmitotic and have reached their fi  nal stage of 
diff  erentiation.
The Purkinje cell–specifi  c Dicer inactivation was achieved 
by Purkinje cell–specifi  c Pcp2 promoter–driven Cre-mediated 
recombination of the Dicer alleles modifi  ed with loxP sites 
(Pcp2-Cre; Dicer  fl  ox/fl  ox; references 7 and 24). To visualize Pur-
kinje cells that express Cre at levels suffi   cient for loxP site re-
combination, we used a reporter system that enables enhanced 
GFP (eGFP) expression after Cre-mediated loxP recombina-
tion (25). In the absence of Cre, the eGFP gene stays dor-
mant but becomes activated after Cre-mediated excision of 
the transcriptional stop cassette that separates the eGFP gene 
from the ubiquitously expressed Rosa26 promoter. The ex-
pression of eGFP combined with analysis of the miRNA 
expression was used to follow the timing and consequence of 
Dicer inactivation in Purkinje cells.
The appearance of eGFP+ Purkinje cells in Pcp2-Cre; 
Dicer fl  ox/fl  ox; Gt(ROSA)26Sor;EGFP was observed around 4 wk 
after birth (Fig. 1, E and H), and eGFP expression was de-
tected in the vast majority of Purkinje cells around 8 wk of 
age (Fig. 1, F and I). At both time points the brain-specifi  c 
miRNA miR-124a, which is highly abundant in control 
Purkinje cells, could not be detected in Purkinje cells of 
Pcp2-Cre; Dicer  fl  ox/fl  ox; Gt(ROSA)26Sor;EGFP mice (Fig. 1, 
J–L). The lack of the highly abundant and widely expressed 
miRNA miR-124a in Purkinje cells, but not in neighboring 
granule cells of Pcp2-Cre; Dicer  fl  ox/fl  ox; Gt(ROSA)26Sor;EGFP 
mice, suggests effi   cient and Purkinje cell–specifi  c Dicer in-
activation at 4 wk of age.
Dicer defi  ciency alters the pattern and levels of miRNA 
expression in Purkinje cells
Similar to nonfractionated brain tissue (12–16), wild-type Pur-
kinje cells express various miRNAs (Table S1, available at 
http://www.jem.org/cgi/content/full/jem.20070823/DC1). 
Many of these miRNAs, such as miR-101a, miR-124a, miR-
125b, miR-134, miR-138 and miR-181a, have a relatively 
broad expression pattern and are present in neurons in numer-
ous parts of the mouse brain. On the other hand, the miRNAs 
miR-9, miR-9*, miR-21, miR-23a, miR-27b, miR-34c, miR-
128a, miR-128b, miR-132, miR-135, miR-136, miR-137, 
miR-153, miR-154, miR-211, miR-218, miR-219, miR-222, 
and miR-338, which are present in whole brain extracts 
(12–16), are not expressed in Purkinje cells (unpublished data).
Figure 1.  Dicer inactivation in postnatal Purkinje cells. 20-μm-
thick cerebellar sections of 8-wk-old control Dicer fl  ox/fl  ox; Gt(ROSA)26Sor;EGFP 
(A, D, and G), and experimental Pcp2-Cre; Dicer fl  ox/fl  ox; Gt(ROSA)26Sor;EGFP 
mice at 4 (B, E, and H) and 8 (C, F, and I) wk of age are shown. To visualize 
Purkinje cells, the cerebella sections were stained with anti-calbindin 
antibody (red). Purkinje cells expressing Cre at levels inducing loxP recom-
bination were visualized by expression of eGFP using an anti-GFP antibody 
(green). The expression of brain-specifi  c miRNA miR-124a in 8-wk-old 
control (J) and Pcp2-Cre; Dicer fl  ox/fl  ox; Gt(ROSA)26Sor;EGFP mice at 4 (K) 
and 8 (L) wk of age was detected by in situ hybridization. Arrows indicate 
individual Purkinje cells, and the Purkinje cell layer is indicated by dashed 
lines. Bars: A–I, 100 μm; J–L, 50 μm.JEM VOL. 204, July 9, 2007  1555
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As judged by in situ analysis of the miRNA expression, 
inactivation of Dicer had diff  erent eff  ects on the timing of 
the disappearance of the Purkinje cell–expressed miRNAs. 
Purkinje cells of 8-wk-old Pcp2-Cre; Dicer  fl  ox/fl  ox mice did not 
express miR-1, miR-29a, miR-30c, miR-101a, miR-103, 
miR-124a, miR-125b, and miR-181a at detectable levels 
(Table S1 and Fig. 2). However, >2 mo after the fi  rst ap-
pearance of the eGFP+ Purkinje cells and hence well beyond 
the time of Dicer inactivation (Fig. 1), the miRNAs miR-107, 
miR-134, miR-138, miR-143, miR-149, miR-212, miR-221, 
and miR-329 remained detectable in the cerebellum of the 
Pcp2-Cre; Dicer  fl  ox/fl  ox mice (Table S1 and Fig. 2). The ob-
served presence of miRNA in the absence of Dicer could 
be genuine and refl  ect diff  erential stability of the miRNAs. 
Alternatively, the revealed in situ hybridization signals may 
refl  ect nonspecifi  c binding of the miRNA-specifi  c probes to 
the pre-miRNAs that accumulate in the absence of Dicer.
Defi  ciency in Dicer and miRNAs leads to degeneration 
of Purkinje cells
The absence of Dicer and the decline in miRNA expression 
in the cerebellum of 8-wk-old Pcp2-Cre; Dicer  fl  ox/fl  ox mice had 
no obvious eff  ect on Purkinje cell morphology or number 
(Figs. 1 and 2). Similar to the control mice, the Purkinje cells 
of 10-wk-old Pcp2-Cre; Dicer  fl  ox/fl  ox mice displayed unaltered 
cell bodies and highly branched dendrites of normal width 
and length (Fig. 3, B, F, J, and M). Analysis of the electro-
physiological properties of Purkinje cells of 10-wk-old Pcp2-
Cre; Dicer  fl  ox/fl  ox mice did not reveal signifi  cant diff  erences 
between the mutant and wild-type Purkinje cells. These re-
sults indicate that there were no obvious changes in the syn-
aptic transmission properties of the parallel or climbing fi  ber 
synapses in 10-wk-old mice. Furthermore, judging from spike 
waveform and repetitive fi  ring properties, voltage-gated ionic 
channel distribution over the Purkinje soma dendritic plas-
malemma was normal (not depicted).
Absence of miRNAs resulted eventually in Purkinje cell 
death and degeneration of the cerebellum (Fig. 3, C, D, G 
and H). Purkinje cells of the 10-wk-old Pcp2-Cre; Dicer  fl  ox/fl  ox 
mice were morphologically similar to control mice (Fig. 3, I, 
J, L, and M). In contrast, the dendrites of 13-wk-old mutant 
Purkinje cells showed spine loss in combination with frag-
mentation of the dendritic compartment, enlarged varicos-
ities, and blebs in the form of pearl-like structures. Notably, 
all of these fragmented dendrites were still enclosed by an in-
tact plasma membrane as determined by their ability to retain 
the fl  uorescent dye (Fig. 3, K and N).
The consequences of miRNA defi  ciency became partic-
ularly obvious between 13 and 17 wk of age. During this 
period, degenerative alterations in Dicer-defi  cient Purkinje 
cells spread from the anterior zone (lobules I–V) to the cen-
tral (lobules VI–VII) and posterior (lobules VIII–IX) zones 
(Fig. 3, C and D).
At the ultrastructural level, dying Purkinje cells displayed 
condensation of the cytoplasm accompanied by the occur-
rence of intracisternal and cytosolic electron-dense structures 
that are reminiscent of protein inclusions, autophagic-like 
vacuoles, and membrane whorls (Fig. 4, A–E). In addition, 
Figure 2.  Expression of miRNAs in Dicer-defi  cient Purkinje cells. 
12-μm-thick cerebellar sections of 8 (A–F) or 13 (G–L) wk control Pcp2-
Cre; Dicer+/fl  ox and experimental Pcp2-Cre; Dicerfl  ox/fl  ox mice are shown. 
The expression of miR-125b (A and B), miR-181a (C and D), and miR-101a 
(E and F), representative of miRNAs that are below detection limit by 8 wk 
of age, and miR-134 (G and H), miR-143 (I and J), and miR-138 (K and L), 
representative for miRNAs that remain detectable at 13 wk of age, were 
detected by in situ hybridization with the corresponding specifi  c probes. 
Bar: A–L, 50 μm.1556  MIRNAS CONTROL NEURODEGENERATION | Schaefer et al. 
few Tdt-mediated dUTP-biotin nick-end labeling (TUNEL)+ 
and hence apoptotic nuclei cells were present in the cerebel-
lar Purkinje cells of Pcp2-Cre; Dicer  flox/fl  ox mice (Fig. 4, F–H), 
whereas many TUNEL+ granule cells were observed (not 
depicted). The apoptotic death of granule cells is likely to be 
induced by dying Purkinje cells as suggested by earlier fi  nd-
ings (26, 27).
In summary, defi  ciency in miRNAs resulted in a slow 
Purkinje cell degeneration. Given the relatively global nature 
of the miRNA defi  ciency, the cause of Purkinje cell death 
is hard to determine. It cannot be excluded that the lack of 
negative regulation of protein expression by miRNAs leads 
to protein accumulation, followed by cell stress response and 
death. In support of this model, we observed accumulation of 
intracisternal and cytosolic protein aggregates in Dicer-defi  cient 
Purkinje cells (Fig. 4, A–E). It is also possible that the lack of 
pre-miRNA processing in the absence of Dicer results in 
accumulation of pre-miRNAs at toxic quantities.
Dicer defi  ciency in Purkinje cells causes ataxia
The depletion of miRNAs and accompanying degeneration 
of Purkinje cells led to ataxia. The motor functions of young 
(8-wk-old) Pcp2-Cre; Dicer  fl  ox/fl  ox mice were indistinguishable 
from those of control mice. However, at 13 wk of age and 
at the time of signifi  cant miRNA decline, the Pcp2-Cre; 
Dicer  fl  ox/fl  ox mice started to develop a slight tremor and mild 
ataxia. These symptoms were aggravated within the next months. 
The analysis of motor function and balance, as examined by 
the rotarod test, displayed a severe impairment in 17-wk-old 
Pcp2-Cre; Dicer  fl  ox/fl  ox mice (Fig. 5 A). The footprint anal  ysis con-
fi  rmed an ataxic walking pattern of the Pcp2-Cre; Dicer  fl  ox/fl  ox 
mice (Fig. 5 B). These results indicate that miRNA defi  ciency 
in Purkinje cells results in a severe cerebellar dysfunction around 
17 wk of age.
Figure 3.  Postnatal inactivation of Dicer leads to cerebellar de-
generation. 12-μm-thick saggital cerebellar sections of 17-wk-old con-
trol Pcp2-Cre; Dicer+/fl  ox mice (A and E) and 10- (B and F), 13- (C and G), 
and 17- (D and H) wk-old experimental Pcp2-Cre; Dicerfl  ox/fl  ox mice are 
shown. Purkinje cells were visualized by immunohistochemistry using an 
antibody to calbindin (brown). Sections are counterstained using Nissl 
stain (blue). Cerebellar lobules are indicated by roman numerals. The sec-
tions outlined by red rectangles in A–D are amplifi  ed in E–H. Morphologi-
cal changes in Dicer-defi  cient Purkinje cells were visualized using 
two-photon images after intracellular injection of the calcium-sensing 
dye Fura 2. 13-wk-old control Pcp2-Cre; Dicer+fl  ox (I and L) and 10- 
(J and M) and 13- (K and N) wk-old Pcp2-Cre; Dicerfl  oxfl  ox mice are shown. 
The individual images were stacked and visualized using Imaris software. 
The sections outlined by white rectangles in I–K are shown in more detail 
in L–N. Bars: A–D, 1 mm; E–H, 50 μm; I–K, 20 μm; L–N, 5 μm.
Figure 4.  Purkinje cell death in Pcp2-Cre; Dicerfl  oxfl  ox mice. Electron 
microscopy images of degenerating Dicer-defi  cient Purkinje cells (A–E). 
Degenerating cells display condensation of the cytoplasm in cell bodies 
(A) and the dendritic compartment (B). Cytoplasmic condensation is as-
sociated with the occurrence of protein accumulations (A), autophagic 
vacuoles, and membrane whorls (B). Region of interests in A are marked 
by squares and shown in more detail (C–E). Membranes surrounding pro-
tein accumulations (C and E) and intracisternal inclusions (C–E) are indi-
cated by arrows. The 12-μm-thick cerebellar section of a 13-wk-old 
Pcp2-Cre; Dicerfl  ox/fl  ox mouse is shown in F–H. Purkinje cells were visual-
ized using anti-calbindin antibody (red), and apoptotic cells were detected 
by TUNEL staining (green). A TUNEL+ degenerating Purkinje cell (indicated 
by a dashed line) can be seen close to a TUNEL− normal-appearing Pur-
kinje cell (arrow). Bars: A, 5 μm; B, 0.2 μm; C–E, 1 μm; F–H, 10 μm.JEM VOL. 204, July 9, 2007  1557
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Conclusion
Here, we show the essential role of Dicer and miRNAs in the 
regulation of postmitotic neuronal survival. Although Dicer 
defi  ciency had no immediate impact on Purkinje cell function, 
the long-term absence of Dicer resulted in a neurodegenerative 
process. This pattern of Purkinje cell degeneration in the ab-
sence of miRNAs bears obvious similarity to processes associ-
ated with the slow progressing neurodegenerative diseases such 
as Alzheimer’s and Parkinson’s disease. Our fi  ndings may help 
to identify individual miRNAs that contribute critically to 
neuronal cell survival. Finally, identifi  cation of miRNAs as 
critical regulators of neuronal survival may provide additional 
insight into the molecular mechanisms of neurodegeneration.
MATERIALS AND METHODS
Mice. Dicerfl  ox/fl  ox (7), Pcp2-Cre (24), and Gt(ROSA)26Sor;EGFP (25) 
mice were intercrossed to generate Pcp2-Cre; Dicer  fl  ox/fl  ox and Pcp2-Cre; 
  Dicer  fl  ox/fl  ox; Gt(ROSA)26Sor;EGFP mice. Genotyping was performed as de-
scribed previously (7, 24, 25). Mice were housed under standard laboratory 
conditions at The Rockefeller University Laboratory Animal Research Cen-
ter. Protocols were approved by The Rockefeller University Institutional 
Animal Care and Use Committee.
Cerebellar slice preparation. Mice were anesthetized with pentobarbitol 
and transcardially perfused as described previously (28). Brains were post-
fi  xed with 4% paraformaldehyde, incubated sequentially in 5, 15, and 
30% wt/vol sucrose in PBS at 4°C, and embedded in Neg-50 medium 
(Richard Allen Scientifi  c). 10–20-μm-thick sagittal sections were mounted 
on Superfrost/Plus slides (Fisher Scientifi  c). Before use, sections were thawed, 
dried for 10 min at room temperature, and washed in PBS.
miRNA detection. MiRNAs were detected by in situ hybridization using 
3′ DIG-labeled LNA oligonucleotide probes from Exiqon purifi  ed using 
Sephadex G25 MicroSpin columns (GE Healthcare). 1–10 pmol of each 
labeled probe was used in 250 μl of hybridization buff  er per slide. Hybrid-
ization was performed according to the published protocol (29).
Immunohistochemistry and indirect immunofl  uorescence. Sections 
were incubated in 0.3% H2O2/PBS at room temperature for 30 min, per-
meabilized with 0.2% Triton/PBS, and blocked with 2% normal goat serum. 
Sections were incubated overnight at 4°C with a primary antibody against 
calbindin D-28 (dilution 1:5000; Swant) and visualized by the avidin–biotin–
peroxidase complex method (Vector Laboratories). The sections were coun-
terstained using standard Nissl-stain. For indirect immunofl  uorescence 
analysis, calbindin D-28 (dilution 1:5000, Swant) and GFP (dilution 1:5,000; 
ab6556; Abcam) antibodies followed by incubation with Alexa Fluor 
546/488–labeled goat anti–mouse/anti–rabbit IgGs (H+L) (dilution 1:500; 
Invitrogen) were used.
TUNEL staining. The In Situ Cell Death Detection kit (fl  uorescein; 
Roche) was used according to the manufacturer’s instructions. Purkinje cells 
were visualized by subsequent immunostaining using an antibody against 
calbindin D-28 (as described above).
All sections from in situ, immunohistochemistry, immunofl  uorescence, 
and TUNEL staining were then visualized on a confocal microscope (LSM510; 
Carl Zeiss MicroImaging, Inc.).
Behavioral analysis. The motor function and balance of control and Pcp2-
Cre; Dicer  fl  ox/fl  ox mice were analyzed via the rotarod task (Economex 
Rotarod; Colombus Instruments) at initial rotation of 1 rpm, accelerating at 
a rate of 0.3 rpm/sec. The time taken for the mice to fall from the rod was 
measured in seconds. If a mouse stayed on the rod until the end of the 3-min 
trial, a time of 180 s was recorded. Mice were subjected to 5 d of consecutive 
trials, and measurements were taken on day 6. Statistical analysis was per-
formed using Student’s t test and Anova single factor analysis.
Footprint patterns were obtained by dipping front paws in red nontoxic 
ink and hind paws in black nontoxic ink and placing mice at one end of a 
dark tunnel.
Electron microscopy. Mice were perfused using 5 ml PBS followed by 
50 ml 2.5% glutaraldehyde in 0.1 M cacodylate acid buff  er, pH 7.4, and pro-
cessed for transmission electron microscopy according to standard protocols.
Two-photon imaging. Imaging was implemented with 100 μM of the 
calcium-sensing dye Fura 2 dissolved in the patch electrode solution. The 
images were obtained using a two-photon laser microscope (AX70; Olym-
pus) as described previously (30). Two-photon images were acquired and 
processed with an in-house program. Imaris software was used for visualiza-
tion and analysis of the individual images.
Online supplemental material. In Table S1, expression of miRNAs in 
Dicer-defi  cient Purkinje cells is shown. The expression of many miRNAs 
reported for whole brain extracts (12–16) has been validated for Purkinje 
cells using in situ hybridization in 8-wk-old C57BL/6 wild-type mice. The 
expression levels of these miRNAs in Purkinje cells of 8- and 13-wk-old 
Pcp2-Cre; Dicer  fl  ox/fl  ox mice relative to control Pcp2-Cre; Dicer+/fl  ox mice are 
indicated. The expression levels of miRNAs in control mice were given 
an arbitrary value of “+++.” The miRNA expression in Purkinje cells of 
Figure 5.  Dicer defi  ciency in Purkinje cells causes ataxia. (A) Ro-
tarod test on Pcp2-Cre; Dicerfl  ox/fl  ox mice compared with their littermate 
controls. Statistical analysis was performed using Anova single factor 
analysis (F = 5.976822099; P = 0.00024395; F crit = 2.41735603). La-
tency to fall from the rod was measured in control Pcp2-Cre; Dicer+/fl  ox 
(gray) and mutant Pcp2-Cre; Dicerfl  ox/fl  ox (black) mice at 8 (control, n = 10; 
mutant, n = 8; P = 0.73494913), 13 (control, n = 10; mutant, n = 7; 
P = 0.28503378), and 17 (control, n = 9; mutant, n = 8; P = 0.00016573) 
wk of age. Results are expressed as means, and error bars represent ± 
SEM. p-values are from the unpaired two-tailed Student’s t test. (B) Foot-
print analysis. Footprints of 17-wk-old male control and Pcp2-Cre; Dicerfl  ox/fl  ox 
mice are shown. The mutant animal exhibits a wide-based ataxic gait. Red, 
front paws; black, hind paws. 1558  MIRNAS CONTROL NEURODEGENERATION | Schaefer et al. 
Pcp2-Cre; Dicer  fl  ox/fl  ox mice is indicated as follows: +++, strong; ++, 
medium; +, weak; −, absent. Table S1 is available at http://www.jem.org/
cgi/content/full/jem.20070823/DC1.
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